Boston Scientific Raises Outlook on Continued Cardiovascular Growth

Core Insights - The medical device company reported increased sales in the third quarter and has raised its full-year earnings guidance due to ongoing growth in its cardiovascular segment [1] Group 1 - The company experienced higher third-quarter sales [1] - The company raised its full-year earnings guidance [1] - Growth in the cardiovascular segment contributed to the positive performance [1]